Clinical Trial

Safety of Cultured Autologous Adult Adipose Derived Mesenchymal Stem Cell Versus Cultured Allogeneic Adult Umbilical-cord Derived Mesenchymal Stem Cell Intrathecal Injection for SCI

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This trial will study the safety and efficacy of intrathecal injection of cultured autologous adult adipose derived mesenchymal stem cells versus cultured allogeneic adult umbilical-cord derived mesenchymal stem cells for the treatment of spinal cord injury
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2021-08-19; most recent amendment 2025-04-15.
Status change: Suspended → Recruiting 2025-04-15
Status change: Recruiting → Suspended 2021-10-07
Trial Details
NCT Number NCT05018793
Lead Sponsor The Foundation for Orthopaedics and Regenerative Medicine
Conditions Spinal Cord Injuries
Enrollment 15 participants
Start Date 2024-12-01
Primary Completion 2028-12 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2025-04-17